GlassScriptPhysician profile
Ewa Radwanska
NPI 1255315602
$609.21
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $375 · 2020: $98.75 · 2021: $102 · 2022: $33.01.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $245.20 | 2019-2021 | |
| Avion Pharmaceuticals | $84.94 | 2019-2022 | |
| Dysis Medical, INC. | $68.76 | 2019 | |
| Lupin INC. | $51.53 | 2019-2020 | |
| Aspira Women'S Health INC | $46.46 | 2021-2022 | |
| Hologic Sales and Service, LLC | $33.77 | 2019-2020 | |
| Coopersurgical, INC. | $31.98 | 2019-2020 | |
| Alfasigma USA, INC. | $18.38 | 2021 | |
| Allergan, INC. | $14.19 | 2019 | |
| Amgen INC. | $14.00 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ewa Radwanska listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.